Literature DB >> 11977157

Growth and maturation in Marfan syndrome.

Gurkan Erkula1, Kevin B Jones, Paul D Sponseller, Harry C Dietz, Reed E Pyeritz.   

Abstract

Understanding the growth pattern in Marfan syndrome is important for prediction of expected growth, prevention of excessive growth by hormone therapy, timing of surgical epiphysiodesis for cessation of growth, and instituting brace treatment for scoliosis. In this study, we analyze growth patterns and generate growth charts for persons with Marfan syndrome. From the charts of 180 clinically diagnosed Marfan patients, longitudinal height and weight measurements were obtained. From this data, growth charts and growth velocity charts were generated for males and females. Skeletal maturation was studied by determining the Risser signs from the x-rays of 71 males and 56 females. From 22 female patients, age of menarche was available and retrieved either by reviewing the charts or contacting the patients. Mean length at birth was 53 +/- 4.4 cm for males and 52.5 +/- 3.5 cm for females. Mean final height was 191.3 +/- 9 cm for males and 175.4 +/- 8.2 cm for females. Mean birth weight was 3.51 +/- 0.74 kg for males and 3.48 +/- 0.68 kg for females. The puberty-associated peak in growth velocity was 2.4 years earlier than the gender-matched general population for males with Marfan syndrome and 2.2 years earlier for females. Age of menarche was 11.7 +/- 2 years of age, which is also early compared to the general population. This study suggests that the growth spurt and pubertal skeletal maturation occur early in Marfan syndrome. The growth curves generated should help more accurately predict adult stature, as well as monitor progression toward it. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11977157     DOI: 10.1002/ajmg.10312

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  23 in total

Review 1.  Coordinating growth and maturation - insights from Drosophila.

Authors:  Jason M Tennessen; Carl S Thummel
Journal:  Curr Biol       Date:  2011-09-27       Impact factor: 10.834

2.  Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.

Authors:  Ronald V Lacro; Lin T Guey; Harry C Dietz; Gail D Pearson; Anji T Yetman; Bruce D Gelb; Bart L Loeys; D Woodrow Benson; Timothy J Bradley; Julie De Backer; Geoffrey A Forbus; Gloria L Klein; Wyman W Lai; Jami C Levine; Mark B Lewin; Larry W Markham; Stephen M Paridon; Mary Ella Pierpont; Elizabeth Radojewski; Elif Seda Selamet Tierney; Angela M Sharkey; Stephanie Burns Wechsler; Lynn Mahony
Journal:  Am Heart J       Date:  2013-03-26       Impact factor: 4.749

3.  Skeletal evolution in Marfan syndrome: growth curves from a French national cohort.

Authors:  Grégoire Benoist; Florence Tubach; Carine Roy; Sabine Rioux; Marlène Michelon-Jouneaux; Bertrand Chevallier; Guillaume Jondeau; Chantal Stheneur
Journal:  Pediatr Res       Date:  2017-09-27       Impact factor: 3.756

4.  Atenolol versus losartan in children and young adults with Marfan's syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lynn A Sleeper; Anji T Yetman; Timothy J Bradley; Steven D Colan; Gail D Pearson; E Seda Selamet Tierney; Jami C Levine; Andrew M Atz; D Woodrow Benson; Alan C Braverman; Shan Chen; Julie De Backer; Bruce D Gelb; Paul D Grossfeld; Gloria L Klein; Wyman W Lai; Aimee Liou; Bart L Loeys; Larry W Markham; Aaron K Olson; Stephen M Paridon; Victoria L Pemberton; Mary Ella Pierpont; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; Angela M Sharkey; Mario P Stylianou; Stephanie Burns Wechsler; Luciana T Young; Lynn Mahony
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

5.  Bone age and onset of puberty in normal boys.

Authors:  Armando Flor-Cisneros; James N Roemmich; Alan D Rogol; Jeffrey Baron
Journal:  Mol Cell Endocrinol       Date:  2006-07-11       Impact factor: 4.102

6.  Associations of Age and Sex With Marfan Phenotype: The National Heart, Lung, and Blood Institute GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) Registry.

Authors:  Mary J Roman; Richard B Devereux; Liliana R Preiss; Federico M Asch; Kim A Eagle; Kathryn W Holmes; Scott A LeMaire; Cheryl L Maslen; Dianna M Milewicz; Shaine A Morris; Siddharth K Prakash; Reed E Pyeritz; William J Ravekes; Ralph V Shohet; Howard K Song; Jonathan W Weinsaft
Journal:  Circ Cardiovasc Genet       Date:  2017-06

7.  Growth failure and outcome in Rett syndrome: specific growth references.

Authors:  Daniel Charles Tarquinio; Kathleen J Motil; Wei Hou; Hye-Seung Lee; Daniel G Glaze; Steven A Skinner; Jeff L Neul; Fran Annese; Lauren McNair; Judy O Barrish; Suzanne P Geerts; Jane B Lane; Alan K Percy
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

Review 8.  Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.

Authors:  Elif Seda Selamet Tierney; Jami C Levine; Shan Chen; Timothy J Bradley; Gail D Pearson; Steven D Colan; Lynn A Sleeper; M Jay Campbell; Meryl S Cohen; Julie De Backer; Lin T Guey; Haleh Heydarian; Wyman W Lai; Mark B Lewin; Edward Marcus; Christopher R Mart; Ricardo H Pignatelli; Beth F Printz; Angela M Sharkey; Girish S Shirali; Shubhika Srivastava; Ronald V Lacro
Journal:  J Am Soc Echocardiogr       Date:  2013-04-10       Impact factor: 5.251

9.  Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lisa M Wruck; Timothy J Bradley; Steven D Colan; Richard B Devereux; Gloria L Klein; Jennifer S Li; L LuAnn Minich; Stephen M Paridon; Gail D Pearson; Beth F Printz; Reed E Pyeritz; Elizabeth Radojewski; Mary J Roman; J Philip Saul; Mario P Stylianou; Lynn Mahony
Journal:  Am Heart J       Date:  2007-10       Impact factor: 4.749

Review 10.  Energy Regulation Mechanism and Therapeutic Potential of Asprosin.

Authors:  Jennifer G Hoffmann; Wei Xie; Atul R Chopra
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.